Cargando…
Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potent cancer cell apoptosis-inducing factor that can induce apoptosis in a variety of cancer cells. However, resistance to TRAIL in cancer cells is a huge obstacle in creating effective TRAIL-targeted clinical therapies. Thus, age...
Autores principales: | Hu, Liubing, Wang, Yan, Chen, Zui, Fu, Liangshun, Wang, Sheng, Zhang, Xinyue, Zhang, Pengchao, Lu, Xueping, Jie, Huiyang, Li, Manmei, Wang, Yifei, Liu, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452544/ https://www.ncbi.nlm.nih.gov/pubmed/31019655 http://dx.doi.org/10.1155/2019/9675450 |
Ejemplares similares
-
Antitumorigenic Effect of Hsp90 Inhibitor SNX-2112 on Tongue Squamous Cell Carcinoma is Enhanced by Low-Intensity Ultrasound
por: Nan, Chuanchuan, et al.
Publicado: (2020) -
Complex Crystal Structure Determination and in vitro Anti–non–small Cell Lung Cancer Activity of Hsp90(N) Inhibitor SNX-2112
por: Zhao, Dong, et al.
Publicado: (2021) -
Suppression of Esophageal Cancer Stem-like Cells by SNX-2112 Is Enhanced by STAT3 Silencing
por: Xu, Dan-dan, et al.
Publicado: (2020) -
Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112
por: Dong, Dong, et al.
Publicado: (2015) -
Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL
por: Chen, Timothy L., et al.
Publicado: (2021)